HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isamu Matsunaga Selected Research

Tuberculosis (Tuberculoses)

2/2014Molecular profiling of Mycobacterium tuberculosis identifies tuberculosinyl nucleoside products of the virulence-associated enzyme Rv3378c.
1/2012Lipidomic discovery of deoxysiderophores reveals a revised mycobactin biosynthesis pathway in Mycobacterium tuberculosis.
1/2012Mycoketide: a CD1c-presented antigen with important implications in mycobacterial infection.
6/2011Glycerol monomycolate, a latent tuberculosis-associated mycobacterial lipid, induces eosinophilic hypersensitivity responses in guinea pigs.
5/2011A microbial glycolipid functions as a new class of target antigen for delayed-type hypersensitivity.
12/2009Mincle is a long sought receptor for mycobacterial cord factor.
12/2008Identification of antibody responses to the serotype-nonspecific molecular species of glycopeptidolipids in Mycobacterium avium infection.
7/2006BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components.
8/2005Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2.
12/2004Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Isamu Matsunaga Research Topics

Disease

10Tuberculosis (Tuberculoses)
02/2014 - 12/2004
7Infections
01/2012 - 08/2005
3Hypersensitivity (Allergy)
06/2011 - 12/2008
2Subacute Sclerosing Panencephalitis (SSPE)
08/2003 - 06/2002
1Coronary Disease (Coronary Heart Disease)
04/2022
1Starvation
01/2012
1Latent Tuberculosis
06/2011
1Latent Infection
06/2011
1Granuloma
12/2009
1Communicable Diseases (Infectious Diseases)
12/2008
1Contact Dermatitis (Eczema, Contact)
10/2008
1Allergic Contact Dermatitis
10/2008
1Neuroblastoma
08/2003
1Vesicular Stomatitis
08/2003

Drug/Important Bio-Agent (IBA)

9LipidsIBA
04/2022 - 08/2005
6Proteins (Proteins, Gene)FDA Link
05/2011 - 06/2002
3AntigensIBA
01/2012 - 11/2005
2GlycolipidsIBA
05/2011 - 12/2008
1Triglycerides (Triacylglycerol)IBA
04/2022
1CholesterolIBA
04/2022
1Attenuated VaccinesIBA
02/2014
1mycobactinsIBA
01/2012
1IronIBA
01/2012
1MetalsIBA
01/2012
1SiderophoresIBA
01/2012
1glycerol monomycolateIBA
06/2011
1Tuberculin (PPD)IBA
05/2011
1CytokinesIBA
05/2011
1C-Type Lectins (C-Type Lectin)IBA
12/2009
1TrehaloseIBA
12/2008
1AntibodiesIBA
12/2008
1AllergensIBA
10/2008
1Monoterpenes (Monoterpenoids)IBA
10/2008
1beta-acaridialIBA
10/2008
1SugarsIBA
11/2005
1Indicators and Reagents (Reagents)IBA
11/2005
1Mycolic Acids (Mycolic Acid)IBA
11/2005
1glucose mycolateIBA
11/2005
1Glucose (Dextrose)FDA LinkGeneric
11/2005
1Glycoproteins (Glycoprotein)IBA
08/2003
1Monoclonal AntibodiesIBA
08/2003

Therapy/Procedure

1Immunotherapy
10/2008